Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct772 - severe acute respiratory syndrome-associated coronavirus ivds - the abbott sars-cov-2 assay is a real-time (rt) reverse transcriptase (rt) polymerase chain reaction (pcr) test intended for the qualitative detection of nucleic acid from the sars-cov-2 in nasopharyngeal (np) and oropharyngeal (op) swabs collected by a healthcare provider, from patients who are suspected of covid-19 infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct702 - multiple-viruses ivds - the abbott resp-4-plex assay is a multiplex real-time reverse transcription (rt) polymerase chain reaction (pcr) test intended for the qualitative detection and differentiation of rna from influenza a virus (flu a), influenza b virus (flu b), respiratory syncytial virus (rsv), and sars-cov-2 in nasopharyngeal (np) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct747 - epstein-barr virus (human herpesvirus 4) ivds - the abbott ebv assay is an in vitro polymerase chain reaction (pcr) assay to quantitate epstein-barr virus (ebv) dna in human edta plasma. the assay is intended for use as an aid in the diagnosis and management of ebv in transplant patients and other immunocompromised patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct910 - interpretive software ivds - analysis software applied to generated results in order to provide further information on patient management

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct355 - viral infectious disease ivds - for the determination of virus markers in human clinical specimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct702 - multiple-viruses ivds - intended to be used in testing to provide information about infection with or exposure to multiple specified viruses

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct923 - multiple infectious organism ivds - to be used in testing to provide information about infection with or exposure to multiple infectious organisms

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct774 - multiple-bacteria ivds - for the testing for infection or exposure to multiple bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct946 - general laboratory reagent and consumables ivds - a general laboratory reagents, products or consumables that is intended to be used as an ivd in the testing of clinical samples.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd molecular division - ct936 - specimen receptacle ivds - specimen vessels used for collecting, containing, preserving or transporting clinical samples.